{"DataElement":{"publicId":"6942146","version":"1","preferredName":"Radiation Therapy Radiosensitizing Agent Administration Plan Type","preferredDefinition":"A response used to determine the planned drugs to be used to potentiate the effectiveness of radiation therapy in destroying unwanted cells.","longName":"6942145v1.0:6942058v1.0","context":"ECOG-ACRIN","contextVersion":"1","DataElementConcept":{"publicId":"6942145","version":"1","preferredName":"Radiation Therapy Radiosensitizing Agent Administration Plan","preferredDefinition":"Treatment of a disease by means of exposure of the target or the whole body to radiation. Radiation therapy is often used as part of curative therapy and occasionally as a component of palliative treatment for cancer. Other uses include total body irradiation prior to transplantation._Drugs used to potentiate the effectiveness of radiation therapy in destroying unwanted cells._The act of the dispensing, applying, or tendering of something to another, such as administration of a medicine._To devise, contrive, or form in design.","longName":"6942142v1.0:6942143v1.0","context":"ECOG-ACRIN","contextVersion":"1","ObjectClass":{"publicId":"6942142","version":"1","preferredName":"Radiation Therapy Radiosensitizing Agent","preferredDefinition":"Treatment of a disease by means of exposure of the target or the whole body to radiation. Radiation therapy is often used as part of curative therapy and occasionally as a component of palliative treatment for cancer. Other uses include total body irradiation prior to transplantation.:Drugs used to potentiate the effectiveness of radiation therapy in destroying unwanted cells.","longName":"C15313:C798","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Radiation Therapy","conceptCode":"C15313","definition":"Treatment of a disease by means of exposure of the target or the whole body to radiation. Radiation therapy is often used as part of curative therapy and occasionally as a component of palliative treatment for cancer. Other uses include total body irradiation prior to transplantation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Radiosensitizing Agent","conceptCode":"C798","definition":"An agent that makes tumor cells more sensitive to radiation therapy.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"92D97847-8C0C-3E2B-E053-F662850AEA81","latestVersionIndicator":"Yes","beginDate":"2019-09-18","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2019-09-18","modifiedBy":"ONEDATA","dateModified":"2019-09-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"6942143","version":"1","preferredName":"Administration Plan","preferredDefinition":"The act of the dispensing, applying, or tendering of something to another, such as administration of a medicine.:To devise, contrive, or form in design.","longName":"C25409:C25619","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Administration","conceptCode":"C25409","definition":"The act of the dispensing, applying, or tendering of something to another, such as administration of a medicine.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Plan","conceptCode":"C25619","definition":"To devise, contrive, or form in design.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"92D97847-8C1D-3E2B-E053-F662850AEA81","latestVersionIndicator":"Yes","beginDate":"2019-09-18","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2019-09-18","modifiedBy":"ONEDATA","dateModified":"2019-09-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008538","version":"1","preferredName":"Therapies","preferredDefinition":"actions or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process (NCI).","longName":"TX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B214D04D-9F05-1CA5-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-18","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-18","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"92D97847-8C2E-3E2B-E053-F662850AEA81","latestVersionIndicator":"Yes","beginDate":"2019-09-18","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2019-09-18","modifiedBy":"GARRIDOJ","dateModified":"2021-03-08","changeDescription":"Created for EA8185, 09/18/2019 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"6942058","version":"1","preferredName":"Regimen Administered Type","preferredDefinition":"Something distinguishable as an identifiable class based on common qualities.","longName":"6942058v1.0","context":"ECOG-ACRIN","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":null,"minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Non-cisplatin regimen","valueDescription":"Negation Cisplatin Regimen","ValueMeaning":{"publicId":"6942060","version":"1","preferredName":"Negation Cisplatin Regimen","longName":"6942060","preferredDefinition":"An operation in which a term denies or inverts the meaning of another term or construction.: A chemotherapy regimen consisting of cisplatin that may be used in the treatment of head and neck, endometrial, vulvar, ovarian, fallopian tube, primary peritoneal, breast, and cervical cancers; and adult intracranial and spinal ependymomas (excluding subependymomas and myxopapillary ependymomas).","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Negation","conceptCode":"C25594","definition":"An operation in which a term denies or inverts the meaning of another term or construction.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Cisplatin Regimen","conceptCode":"C160011","definition":"A chemotherapy regimen consisting of cisplatin that may be used in the treatment of head and neck, endometrial, vulvar, ovarian, fallopian tube, primary peritoneal, breast, and cervical cancers; and adult intracranial and spinal ependymomas (excluding subependymomas and myxopapillary ependymomas).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"92D9053B-0224-1D03-E053-F662850AF791","latestVersionIndicator":"Yes","beginDate":"2019-09-18","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2019-09-18","modifiedBy":"ONEDATA","dateModified":"2019-09-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"92D9053B-023F-1D03-E053-F662850AF791","beginDate":"2019-09-18","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2019-09-18","modifiedBy":"ONEDATA","dateModified":"2019-09-18","deletedIndicator":"No"},{"value":"Cisplatin regimen","valueDescription":"Cisplatin Regimen","ValueMeaning":{"publicId":"6942682","version":"1","preferredName":"Cisplatin Regimen","longName":"6942682","preferredDefinition":"A chemotherapy regimen consisting of cisplatin that may be used in the treatment of head and neck, endometrial, vulvar, ovarian, fallopian tube, primary peritoneal, breast, and cervical cancers; and adult intracranial and spinal ependymomas (excluding subependymomas and myxopapillary ependymomas).","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cisplatin Regimen","conceptCode":"C160011","definition":"A chemotherapy regimen consisting of cisplatin that may be used in the treatment of head and neck, endometrial, vulvar, ovarian, fallopian tube, primary peritoneal, breast, and cervical cancers; and adult intracranial and spinal ependymomas (excluding subependymomas and myxopapillary ependymomas).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"92EE9336-9D3A-5E7D-E053-F662850AF406","latestVersionIndicator":"Yes","beginDate":"2019-09-19","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2019-09-19","modifiedBy":"ONEDATA","dateModified":"2019-09-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"92EE9336-9D55-5E7D-E053-F662850AF406","beginDate":"2019-09-19","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2019-09-19","modifiedBy":"ONEDATA","dateModified":"2019-09-19","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008538","version":"1","preferredName":"Therapies","preferredDefinition":"actions or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process (NCI).","longName":"TX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B214D04D-9F05-1CA5-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-18","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-18","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2234813","version":"1","preferredName":"Type","preferredDefinition":"Type; a subdivision of a particular kind of thing.","longName":"C25284","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"F970CDF6-F90E-21D3-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-14","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-06-14","modifiedBy":"SBR","dateModified":"2005-09-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"92D9053B-020C-1D03-E053-F662850AF791","latestVersionIndicator":"Yes","beginDate":"2019-09-18","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2019-09-18","modifiedBy":"GARRIDOJ","dateModified":"2021-03-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"3852751","version":"1","longName":"Therapeutic","context":"ECOG-ACRIN","ClassificationSchemeItems":[{"publicId":"3314497","version":"1","longName":"Treatment","context":"ECOG-ACRIN"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"Radiosensitizing option durin","type":"Preferred Question Text","description":"Radiosensitizing option during RT","url":null,"context":"ECOG-ACRIN"}],"origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"92DA7512-DB9C-7946-E053-F662850A976E","latestVersionIndicator":"Yes","beginDate":"2019-09-18","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2019-09-18","modifiedBy":"GARRIDOJ","dateModified":"2021-03-08","changeDescription":"Created for EA8185, 09/18/2019 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}